Geburtsdatum
Alter
15.07.1992 (Alter: 31)
31
(15.07.1992)
Draft
Saison 14 / #23 (CLE)
Saison 14 / #23
(CLE)
Team
Boston Celtics
Celtics
Career Earnings
360.80 Mio
Gesamt
TOT
18
13105
7050
2290
1092
479
157
375
1821
1821
952
2227
566
652
403
630
1190
494
377
24
15
0
6331
Schnitt
AVG
26.5
14.3
4.6
2.2
1.0
0.3
0.8
3.7
7.0
1.9
4.5
1.1
1.3
0.8
1.3
2.4
52.9%
42.7%
86.8%
27.4
20.9
1.3
0.8
0.0
12.8
20.7%
17.9
2.9
0.76
0.25
Career High
High
36
55
12
8
4
5
5
12
24
15
22
8
10
5
6
39
Gesamt
TOT
10
1065
631
155
85
28
12
36
0
94
94
194
69
77
21
39
-61
39
21
0
1
0
549
Schnitt
AVG
27.3
16.2
4.0
2.2
0.7
0.3
0.9
3.6
7.3
2.4
5.0
1.8
2.0
0.5
1.0
-1.6
49.1%
48.5%
89.6%
3.9
2.1
0.0
0.1
0.0
14.1
0.0%
18.4
0.0
0.00
0.00
Career High
High
32
22
7
5
2
1
2
5
11
4
7
9
10
2
2
18
Gesamt
TOT
1176
622
231
139
42
17
42
219
395
46
109
50
71
46
63
235
42
42
4
1
0
577
Schnitt
AVG
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
13.7
22.0%
18.9
3.31
0.67
0.27
Season High
High
33
31
10
7
3
2
4
11
18
4
6
4
6
4
5
30
87.5%
75.0%
75.0%
26
37.1%
38.8
7.00
2.00
1.00
38
83
CLE
11.0
554
168
73
28
23
2
11
35
71
28
74
14
16
8
22
7
49.3%
37.8%
87.5%
19
19
0
0
0
9
13.6%
10.3
2.55
1.05
0.09
37
81
IND
26.0
732
266
100
50
27
0
23
66
102
40
83
14
17
26
30
-62
64.7%
48.2%
82.4%
26
24
1
0
0
8
12.9%
13.9
2.17
0.90
0.00
36
82
IND
26.0
714
592
117
46
13
3
14
122
243
85
173
93
100
25
47
34
50.2%
49.1%
93.0%
27
27
1
1
0
18
28.5%
25.0
3.29
0.28
0.06
35
82
IND
26.0
635
268
103
57
25
0
28
65
132
35
86
33
43
17
24
149
49.2%
40.7%
76.7%
29
0
2
0
0
9
17.9%
13.7
2.04
1.04
0.00
34
85
TOR
26.0
717
499
112
69
25
10
25
131
242
71
135
24
27
17
23
-50
54.1%
52.6%
88.9%
28
10
3
0
0
15
26.4%
22.9
2.76
1.09
0.43
33
85
TOR
26.0
669
349
106
46
19
5
16
97
200
48
121
11
11
24
17
47
48.5%
39.7%
100.0%
25
26
2
0
0
14
23.1%
15.4
2.88
1.12
0.29
32
85
LAC
25.0
646
598
86
46
17
9
20
92
155
125
209
39
40
11
33
405
59.4%
59.8%
97.5%
25
25
2
0
0
16
27.0%
30.8
2.30
0.52
0.27
31
84
POR
25.0
797
402
110
73
27
4
20
122
214
40
122
38
39
21
40
-21
57.0%
32.8%
97.4%
27
27
2
0
0
14
20.0%
16.1
3.65
0.68
0.10
30
85
DAL
25.0
717
429
142
65
25
12
25
116
222
57
158
26
33
24
38
-33
52.3%
36.1%
78.8%
26
27
2
2
0
16
26.0%
18.0
2.60
0.66
0.32
29
85
MIL
25.0
1254
809
292
112
47
15
32
171
349
139
353
50
55
43
66
103
49.0%
39.4%
90.9%
45
45
3
5
0
17
22.0%
20.1
3.50
0.71
0.23
28
86
BOS
25.0
1044
632
188
60
36
32
24
144
248
108
256
28
32
16
52
316
58.1%
42.2%
87.5%
40
39
2
0
0
14
24.0%
19.8
2.50
0.69
0.62
27
82
ORL
12.0
1176
622
231
139
42
17
42
219
395
46
109
50
71
46
63
235
55.4%
42.2%
70.4%
42
42
4
1
0
14
22.0%
18.9
3.31
0.67
0.27
26
82
ORL
12.0
993
607
188
102
50
17
36
185
357
56
122
69
76
53
59
33
51.8%
45.9%
90.8%
33
0
0
4
0
17
24.0%
21.3
2.83
0.85
0.29
25
78
ORL
12.0
681
208
140
83
26
10
18
83
153
5
29
26
34
26
36
-31
54.2%
17.2%
76.5%
26
28
0
0
0
8
9.0%
13.4
4.61
0.72
0.28
24
80
SAC
12.0
434
161
86
30
21
6
9
57
108
8
29
24
26
17
17
26
52.8%
27.6%
92.3%
15
0
0
1
0
10
13.0%
14.5
3.33
1.24
0.35
23
78
CLE
15.4
87
31
11
3
3
2
1
8
13
4
8
3
4
2
8
-9
61.5%
50.0%
75.0%
6
0
0
0
0
4
1.0%
13.1
3.00
0.38
0.25
21
79
DEN
8.0
560
137
62
48
19
7
19
33
95
20
91
11
14
6
25
-111
34.7%
22.0%
78.6%
28
11
0
0
0
8
0.0%
5.1
2.53
0.76
0.28
20
80
GSW
8.0
695
272
143
35
34
6
12
75
143
37
69
13
14
21
30
152
52.4%
53.6%
92.9%
27
27
0
1
0
9
0.0%
15.5
2.92
1.13
0.20
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2019-02-03
02-03
ORL
BKN
23
6
3
1
1
0
1
3
8
0
0
0
0
1
1
21
37.5%
--
--
x
9
0.0%
5.4
1.00
1.00
0.00
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
NYK
30
20
2
0
0
0
0
4
4
4
6
0
0
0
0
-7
80.0%
66.7%
--
x
10
14.9%
23.5
--
--
--
2019-02-01
02-01
ORL
TOR
31
19
6
3
1
0
1
6
12
1
1
4
4
4
2
-6
53.8%
100.0%
100.0%
x
16
19.7%
23.2
3.00
0.50
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
MIL
31
17
9
6
1
0
1
7
12
1
3
0
0
1
1
15
53.3%
33.3%
--
x
16
22.0%
21.8
6.00
1.00
0.00
2019-01-27
01-27
ORL
ATL
29
13
5
3
0
0
2
5
12
1
4
0
0
1
0
8
37.5%
25.0%
--
x
18
25.8%
7.7
1.50
--
--
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIA
25
16
4
3
2
0
0
5
8
2
3
0
0
0
0
17
63.6%
66.7%
--
x
11
22.5%
27.3
--
--
--
2019-01-11
01-11
ORL
PHI
29
16
8
4
0
0
0
5
6
2
2
0
0
0
1
17
87.5%
100.0%
--
x
8
12.5%
26.0
--
0.00
0.00
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
CLE
23
15
2
3
0
0
1
4
8
1
3
4
4
1
1
21
45.5%
33.3%
100.0%
x
14
28.5%
18.9
3.00
0.00
0.00
2018-12-21
12-21
ORL
WAS
33
12
6
2
2
2
2
6
14
0
3
0
0
0
3
-6
35.3%
0.0%
--
x
19
24.1%
6.8
1.00
0.67
0.67
2018-12-13
12-13
ORL
DET
30
10
5
4
3
0
1
2
3
1
5
3
4
0
5
3
37.5%
20.0%
75.0%
x
11
16.0%
13.0
4.00
0.60
0.00
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-26
11-26
ORL
CHA
29
13
6
4
1
0
1
5
7
1
1
0
0
1
1
16
75.0%
100.0%
--
x
9
12.6%
20.8
4.00
1.00
0.00
2018-11-25
11-25
ORL
CHI
32
15
9
2
1
1
0
6
10
1
3
0
0
4
0
1
53.8%
33.3%
--
x
13
18.2%
21.1
--
--
--
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00